Two-12 months carcinogenicity studies with pregabalin were performed in rats and mice. No tumours have been observed in rats at exposures approximately 24 times the mean human publicity at the maximum proposed clinical dose of 600 mg/day. In mice, no increased incidence of tumours was uncovered at exposures similar to https://robertq110nxf0.wikitelevisions.com/user